1. Introduction {#j_sjph-2017-0012_s_001}
===============

Medically unexplained symptoms (MUS) are very common in family medicine despite being a poorly-defined clinical entity; approximately 2.5%-25% of patients who visit a family physician (FP) complain of physical symptoms for which no physical pathology can be found even after a number of examinations ([@j_sjph-2017-0012_ref_001]-[@j_sjph-2017-0012_ref_002]). The diagnosis of MUS still has a very negative connotation for patients ([@j_sjph-2017-0012_ref_003]). A recent Slovenian study ([@j_sjph-2017-0012_ref_004]) observed an 8.6% frequency of MUS in family medicine practice attendees, which shows that MUS is as much a public health care problem in Slovenia as anywhere else in the world ([@j_sjph-2017-0012_ref_001], [@j_sjph-2017-0012_ref_002]). Other Slovenian studies on the new project of model practices in family medicine did not show any more successful treatment of patients with MUS ([@j_sjph-2017-0012_ref_005]).

Some studies show that depression and anxiety disorders are comorbid with medically unexplained conditions ([@j_sjph-2017-0012_ref_006]). In the literature, MUS are often described as equivalent to somatoform disorders, but studies show that only approximately 25% of MUS patients meet the criteria for one of the somatoform disorders according to the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV-TR), and the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10) ([@j_sjph-2017-0012_ref_007]-[@j_sjph-2017-0012_ref_009]), which means that MUS is a problem which goes beyond the definition and criteria for somatoform disorders. Recent international studies emphasise the importance of one or more psychosocial stressors that could not be identified either by the patients or the physicians ([@j_sjph-2017-0012_ref_010]). Following an explanation of how such stressors can affect the occurrence of physical symptoms in patients, five areas were researched in detail, namely everyday stress and problems in life, prolonged effect/effects of childhood stress, physical manifestation of depression, posttraumatic stress disorder (PTSD), and anxiety ([@j_sjph-2017-0012_ref_011]).

According to the results ([@j_sjph-2017-0012_ref_012]), the pharmacological treatment of MUS is among the most common interventions. Also very common is the use of cognitive behavioural methods and other non-specific interventions. Cognitive behavioural approaches proved to be the most effective ([@j_sjph-2017-0012_ref_012]) and were confirmed ([@j_sjph-2017-0012_ref_013]) as being useful in reducing medically unexplained chronic fatigue in the paediatric population (aged from 11 to 18 years).

The aim of our study was to examine the effect of an educational intervention (EI) for FPs on the MUS patients' self-rated quality of life, treatment satisfaction and relationship with the physician.

2. Methods {#j_sjph-2017-0012_s_002}
==========

2.1. Participants and Procedures {#j_sjph-2017-0012_s_002_s_001}
--------------------------------

### 2.1.1. Participating Physicians {#j_sjph-2017-0012_s_002_s_001_s_001}

A total of 90 family medicine practices or FPs from across Slovenia were invited to participate in a multi-centre longitudinal intervention study. The recruitment of the physicians was carried out between January and March 2012. The practices were selected by random sampling from the publicly available register of all Slovenian family medicine practices provided by the Institute of Public Health of the Republic of Slovenia (ZZZS) ([@j_sjph-2017-0012_ref_014]). This register enabled us to include in our study a population with a great socioeconomic diversity and different ethnic backgrounds. Out of 90 invited physicians, a total of 63 (70%) decided to take part in the first phase of our study (7.5% of all family medicine teams in Slovenia) ([@j_sjph-2017-0012_ref_014]).

The FPs were mailed the Study Protocol and Questionnaires. After completing the first phase of the study, half of the physicians (32 of 63) were invited to attend a two-day training on the identification and treatment of patients with MUS. All the invited physicians attended the training and were taught about the basic principles of cognitive behavioural therapy (CBT), mental illness diagnostic criteria and a proper multidisciplinary approach toward patients with MUS. Finally, a Model of Careful Assessment (MCA) as an intervention in the treatment of patients with MUS was introduced and trained. In the continuation of the study, those physicians represented the intervention group. Every three months during a 12-month period, they were sent by post a clinical vignette of a patient with MUS, which was also used in the workshops, as well as a MCA. In this way, the intervention group participants were able to refresh their newly gained knowledge. The physicians from the control group were sent only the technical instructions for the conduct of the study.

In the second phase of the study, a total of 45 (23 from the intervention group and 22 from the control group) of the participating physicians decided to continue their participation, which represented 5.36% of all family medicine teams in Slovenia ([Figure 1](#j_sjph-2017-0012_fig_001){ref-type="fig"}).

In physicians, attendance at the two-day training counted as inclusion criteria for intervention group, which in fact acted as an interventional variable when following up several characteristics in MUS patients.

![A graphic presentation of the number of physicians participating in either phase of the study.](j_sjph-2017-0012_fig_001){#j_sjph-2017-0012_fig_001}

### 2.1.2. Participating Patients {#j_sjph-2017-0012_s_002_s_001_s_002}

For three consecutive 'typical' working days, determined by the participating physicians themselves, patients aged between 18 and 80 years who came to the practice for any reason and who were suspected of MUS were invited by their physician to participate in this study. The physicians screened a total of 4,921 patients and invited 1,410 of them; 584 (41.42%) of the invited patients refused to take part in the study. The most common reason for nonparticipation was lack of time.

In the end, a total of 826 (58.58%) of patients decided to participate in the first phase of the study, with 422 of these fulfilling the criteria for MUS (patient age between 18 and 80 years, suspicion of MUS, and fulfilled criteria for MUS from Questionnaire B) and 404 patients not fulfilling the criteria for MUS. The latter were not followed-up.

In the second phase of the study (carried out between April 2012 and June 2013), 510 of the 1,410 initially invited patients (36.17%) decided to continue their participation; of those, 269 patients had MUS. Those 269 MUS patients were analysed after the 12-month period.

[Figure 2](#j_sjph-2017-0012_fig_002){ref-type="fig"} shows the participation of patients by the study phase.

![A graphic presentation of the number of patients participating in either phase of the study.](j_sjph-2017-0012_fig_002){#j_sjph-2017-0012_fig_002}

2.2. Instruments {#j_sjph-2017-0012_s_002_s_002}
----------------

The FPs were asked to complete Questionnaire A (demographic information about the physician and practice), whereas the patients answered Questionnaire B, consisting of the PHQ-15 (Patient Health Questionnaire) for assessing the severity of non-specific somatic symptoms that have been shown to be highly associated with MUS diagnosis in the past four weeks ([@j_sjph-2017-0012_ref_015]), and three additional questions regarding the patients' problems and the physicians' clinical opinion (i.e., the symptom has been present for at least three months, the symptom has been causing clinically significant problems for the patient, and the symptom cannot be explained by any known physical disease) ([@j_sjph-2017-0012_ref_001]). A PHQ-15 score of 15 or higher and positive answers to all three additional questions formed the criteria for the inclusion of patients with MUS. The patients were also asked to complete Questionnaire D, which included theEQ-5D-3L (EuroQoL 5D-3L) instrument rating quality of life ([@j_sjph-2017-0012_ref_016]), as well as the 4DSQ (Four-Dimensional Symptom Questionnaire) for assessing depression, anxiety, stress and somatisation ([@j_sjph-2017-0012_ref_017]), the WI (Whiteley Hypochondriasis Index) ([@j_sjph-2017-0012_ref_018]), the MISS-21 (Medical Interview Satisfaction Scale) for measuring patient satisfaction ([@j_sjph-2017-0012_ref_019]), and the PEI (Patient Enablement Instrument) for assessing the physician-patient relationship ([@j_sjph-2017-0012_ref_020]).

Questionnaires A and B were completed only in the first phase of the study (0 months), and Questionnaire D was completed at inclusion into the study (0 months) and 12 months later. The latest data are crucial for this study aim, providing 269 MUS patients' reflection on depression, anxiety, stress and somatisation, satisfaction, and also assessing the physician-patient relationship.

2.3. Statistical Analysis {#j_sjph-2017-0012_s_002_s_003}
-------------------------

Those parts of the questionnaire which were adapted from international questionnaires were assessed for their construct validity (using factor analysis) and measuring reliability. The reliability of all measures was exemplary (Cronbach's alpha α \> 0.80). To analyse the differences in MUS patients before and after the EI, we used the paired sample t-test for numeric variables and the chi-square test for categorical variables. Statistical significance for the entire analysis was set at a 5% risk level (p≤0.05).

The data were statistically processed using SPSS 21.0 statistical software (IBM Corp., Grouponk, NY, USA).

3. Results {#j_sjph-2017-0012_s_003}
==========

At the beginning of the recruitment process, there were 422 patients in the group with MUS, and 404 patients in the group without MUS.

**Gender structure**: The whole cohort consisted of 826 patients; 62.2% were women and 37.8% were men. The number of women was higher in the MUS patient group (64.9%), compared to the group without MUS (59.4%). However, this relatively higher proportion of women in the MUS group was not statistically significant (×2=2.679; df=1; p=0.102).

**Patients' age**: The mean age of patients was 49.40±12.29 years. The mean age of patients with MUS was 50.35±11.49 years, which is approximately two years older than the mean age of patients without MUS (48.41±13.01 years; p=0.040).

**Educational level and employment status**: The MUS group included 23.7% of patients who were primary school graduates (primary school leaving age is 14 in Slovenia), whereas in the group without MUS there were 13.9% of patients with primary school only; secondary education was completed by significantly fewer patients in the MUS group (29.1%) as compared to 38.9% of patients without MUS (p=0.002). The majority of patients had completed vocational (31.7%) and secondary (33.9%) education; those were followed by primary education (18.9%), postsecondary, higher or university education (14.4%), and Master's or Doctoral degree (1.1%). Most patients were in employment (39.8%), followed by retired people (26.9%) and the unemployed (21.3%); 9.0% of patients indicated that they were self-employed or farmers, whereas 3.0% were secondary school or university students. A statistically significant greater proportion of patients with MUS were unemployed (with MUS: 28.9%; without MUS: 13.4%) a smaller proportion of them were employed (with MUS: 34.1%; without MUS: 45.7%), and a smaller proportion of them had secondary school or university student status (with MUS: 1.7%; without MUS: 4.5%; p=0.000).

**Other characteristics**: There were no statistically significant differences observed between the two groups of patients in terms of settlement size (p=0.8865). Patients with MUS differed from others by the number of persons in the household (p = 0.028). In other words, patients with MUS lived in significantly larger households (3.39±1.46 members vs. 3.17±1.45 members).

**3.1 The Effect of EI on Self-Rated Quality of Life, MUS, Hypochondriasis, Patient Satisfaction, and the Physician-Patient Relationship**

4. Discussion {#j_sjph-2017-0012_s_004}
=============

The aim of our study was to investigate the effect of the EI in physicians on some factors associated with quality of life and the perception of the relationship with the selected physician in patients with MUS. The mean values before and after the intervention showed that after the EI, patients with MUS gave a lower (total) mean rating of their health issues and a higher rating of their quality of life, and they also had a more positive opinion about their relationship with the physician (p\<0.05; [Table 1](#j_sjph-2017-0012_tab_001){ref-type="table"}). However, there were no differences in the (total) rating of treatment satisfaction before and after the EI (p=0.423) ([Table 1](#j_sjph-2017-0012_tab_001){ref-type="table"}). Significant differences in the symptoms in patients with MUS before and after the intervention were confirmed for stress, somatisation and hypochondriasis (p\<0.05; [Table 2](#j_sjph-2017-0012_tab_002){ref-type="table"}).

###### 

The analysis of differences in the (total) rating of health issues, quality of life, treatment satisfaction and the physicianpatient relationship in patients with MUS, before and after the intervention.

                                            BEFORE INTERVENTION                                 AFTER INTERVENTION   *P*
  --------------------------- ------------- --------------------------------------------------- -------------------- ---------
                                            **(Total) rating of healtd issues**                                      
                                                                                                                     
  Mean ± standard deviation                 8.51±1.40                                           8.16±1.45            *0.000*
  95% confidence interval                                                                                            
                              lower limit   8.38                                                7.98                 
                              upper limit   8.65                                                8.33                 
                                                                                                                     
                                            **Quality of life (self-rated healtd)**                                  
                                                                                                                     
  Mean ± standard deviation                 44.81±11.927                                        48.21±11.722         *0.000*
  95% confidence interval                                                                                            
                              lower limit   43.67                                               46.80                
                              upper limit   45.95                                               49.62                
                                                                                                                     
                                            **(Total) rating of treatment satisfaction**                             
                                                                                                                     
  Mean ± standard deviation                 3.72±0.400                                          3.71±0.304           *0.423*
  95% confidence interval                                                                                            
                              lower limit   3.68                                                3.68                 
                              upper limit   3.76                                                3.75                 
                                                                                                                     
                                            **Opinion on tde physician-patient relationship**   1                    
                                                                                                                     
  Mean ± standard deviation                 2.69±0.48                                           2.39±0.53            *0.000*
  95% confidence interval                                                                                            
                              lower limit   2.65                                                2.33                 
                              upper limit   2.74                                                2.45                 

###### 

The analysis of differences in the symptoms of MUS patients, and the hypochondriasis index before and after the intervention.

                                                     BEFORE INTERVENTION   AFTER INTERVENTION    *P*
  ------------------------------------ ------------- --------------------- --------------------- ---------
  **Depression**                                     **n = 260 (61.6%)**   **n = 170 (63.2%)**   
  (Criterion: depression \>2)                                                                    
  Mean ± standard dev\'ation                         3.92±3.270            3.85±3.100            *0.051*
  95% confidence interval                                                                        
                                       lower limit   3.61                  3.48                  
                                       upper limit   4.24                  4.22                  
                                                                                                 
  **Anxiety**                                        **n = 126 (29.9%)**   **n=77 (28.6%)**      
  (Criterion: anxiety \>8)                                                                       
  Mean ± standard dev\'ation                         6.53±5.325            6.36±5.145            *0.558*
  95% confidence interval                                                                        
                                       lower limit   6.02                  5.74                  
                                       upper limit   7.04                  6.97                  
                                                                                                 
  **Stress**                                         **n=367 (87.2%)**     **n = 237 (88.1%)**   
  (Criterion: stress \>10)                                                                       
  Mean ± standard deviation                          19.57±7.216           18.64±6.701           *0.000*
  95% confidence interval                                                                        
                                       lower limit   18.88                 17.83                 
                                       upper limit   20.26                 19.44                 
                                                                                                 
  **Somatisation**                                   **n=393 (93.1%)**     **n=248 (92.2%)**     
  (Criterion: somatisation \>10)                                                                 
  Mean ± standard deviation                          19.49±5.728           18.54±5.585           *0.000*
  95% confidence interval                                                                        
                                       lower limit   18.94                 17.87                 
                                       upper limit   20.04                 19.21                 
                                                                                                 
  **Whiteley Hypochondriasis Index**                 **n=422 (100%)**      **n=269 (100%)**      
  Mean ± standard dev'ation                          45.31±9.732           44.16±8.785           *0.000*
  95% confidence interval                                                                        
                                       lower limit   44.38                 43.11                 
                                       upper limit   46.24                 45.22                 

The study topic corresponds to the current public health care policies and needs in Slovenia and around the world ([@j_sjph-2017-0012_ref_011], [@j_sjph-2017-0012_ref_022], [@j_sjph-2017-0012_ref_023]). The EI for physicians was prepared as a combination of several different approaches to treating patients with MUS in accordance with recommendations in the literature ([@j_sjph-2017-0012_ref_021]), focusing on practical work in small groups and presenting the MCA tool ([@j_sjph-2017-0012_ref_024]). A German study from 2007 ([@j_sjph-2017-0012_ref_025]) investigated the effect of a one-session EI using a cognitive-behavioural approach, observing a reduced number of visits to practices and fewer somatisation symptoms at 6-month follow-up. In our study, the intervention's impact was evaluated through patients' self-rated quality of life, treatment satisfaction, and their assessment of the physician-patient relationship, as well as through somatisation, anxiety, depression and hypochondriasis ([Table 1](#j_sjph-2017-0012_tab_001){ref-type="table"}, [Table 2](#j_sjph-2017-0012_tab_002){ref-type="table"}). We could not find such criteria (as a whole) in the available body of literature.

4.1. EI and Self-Rated Quality of Life {#j_sjph-2017-0012_s_004_s_001}
--------------------------------------

After the EI, patients with MUS gave a lower (total) mean rating of their health issues and a higher self-rating of their quality of life ([Table 1](#j_sjph-2017-0012_tab_001){ref-type="table"}). A more recent Dutch study ([@j_sjph-2017-0012_ref_026]), which also employed the EQ-5D questionnaire, observed that MUS have a greater effect on the quality of life in a younger population (aged less than 65 years). A Slovenian study from 2014 ([@j_sjph-2017-0012_ref_016]) found that -- considering the results of the EQ-5D questionnaire -- the presence of psychological symptoms is associated with lower quality of life. Klemenc Ketiš et al. ([@j_sjph-2017-0012_ref_016]) observed a correlation between factors identified using the EQ-5D questionnaire (the presence of chronic disease, pain, and anxiety and depression), which are independently associated with psychological symptoms. In addition, findings of other authors ([@j_sjph-2017-0012_ref_027]) confirm the correlation between psychological and unexplained symptoms, and lower quality of life, as measured by the EQ-5D questionnaire. We reached the same conclusion with regard to the patients' quality of life, and we also confirmed the El's effect on patients with MUS in terms of their quality of life.

4.2. EI and Depression, Anxiety, Stress, and Somatisation and Hypochondriasis {#j_sjph-2017-0012_s_004_s_002}
-----------------------------------------------------------------------------

In our study, patients with MUS had a lower mean level of depression, anxiety, stress and somatisation after the EI, and this reduction in stress and somatisation was confirmed as statistically significant ([Table 2](#j_sjph-2017-0012_tab_002){ref-type="table"}). Similar to our study, the majority of other studies ([@j_sjph-2017-0012_ref_012], [@j_sjph-2017-0012_ref_028]) found that improved communication with the MUS patient is beneficial, as is the use of empathy in the physician-patient relationship, or better acceptance of MUS patients as they are.

The analysis of differences in hypochondriasis in patients with MUS before and after the EI ([Table 2](#j_sjph-2017-0012_tab_002){ref-type="table"}) confirmed that the intervention -- i.e., capacity building in physicians -- significantly reduced (but did not eliminate altogether) hypochondriasis in MUS patients. A recent German study from 2013 ([@j_sjph-2017-0012_ref_029]) analysed the effect of the EI (a multidisciplinary approach and the inclusion of a psychosomatic therapist in the education of family physicians) on the treatment of MUS patients, and found a decrease in the level of hypochondriasis, which is comparable to the findings of our study.

4.3. EI and Patients' Treatment Satisfaction {#j_sjph-2017-0012_s_004_s_003}
--------------------------------------------

Statistical analysis did not reveal significant differences in the (total) rating of treatment satisfaction before and after the EI ([Table 1](#j_sjph-2017-0012_tab_001){ref-type="table"}). Similarly, a study by Jackson, J. et al. ([@j_sjph-2017-0012_ref_030]) found that there were no significant differences in the treatment satisfaction of patients with MUS compared to patients without MUS. A study from Sri Lanka ([@j_sjph-2017-0012_ref_031]) investigated the effect of an intervention on several factors, including patients' treatment satisfaction, and showed that patient satisfaction increased after the EI (mainly the education of physicians in cognitive-behavioural techniques). Differences in the findings of various authors and those of this study are probably a result of the use of different types of intervention and different questionnaires for analysing patient satisfaction; this is why the findings are difficult to compare.

4.4. EI and the Patient-Physician Relationship {#j_sjph-2017-0012_s_004_s_004}
----------------------------------------------

We found ([Table 1](#j_sjph-2017-0012_tab_001){ref-type="table"}) that intervention in patients with MUS significantly improved their opinion of the physician-patient relationship. The results of our study match those of another study carried out in Scotland ([@j_sjph-2017-0012_ref_032]), which showed that intervention in MUS patients significantly improved their opinion of the physician-patient relationship, but failed to confirm significant differences in the (total) rating of treatment satisfaction before and after the EI. We could not find any data on the intervention's effect on the physician-MUS patient relationship in comparable foreign studies ([@j_sjph-2017-0012_ref_033], [@j_sjph-2017-0012_ref_034]), which provides an opportunity for new research in this field, and for improving the quality of treatment of patients with MUS.

4.5. Limitations of the Study {#j_sjph-2017-0012_s_004_s_005}
-----------------------------

The criteria for including patients in the group of patients with MUS are non-standardised, due to the non-existence of an accurate definition of MUS. For the purposes of this study, the inclusion criteria were based on a large review of the literature, and represented a combination of several factors to reduce this limitation. The acquisition of data excluded all physicians and patients who refused to participate in the study.

The study included patients who had visited their physician for three 'typical' working days, coming to the practice for different reasons, many due to an acute disease or the worsening of a chronic disease. Because of this, frequent visitors to family medicine practices had a greater chance of being included in the study. This study limitation could have been eliminated if we had included random sampling of patients using a register of family medicine practice patients, but the participation of patients would have most probably been even lower.

The decrease in the number of participating FPs and patients was relatively large by the end of the study, which is also reported by other researchers of MUS ([@j_sjph-2017-0012_ref_012], [@j_sjph-2017-0012_ref_035]). We also failed to track possible patterns within the MUS patients group after one-year-period, and did not analyse characteristics of the fall-out patients.

The EI was relatively short (two days) and was a 'one-off.' The EI attendees were probably more motivated to participate (a personal interest in this topic) than other physicians.

The success of the EI was at first limited to the observation of quality of life, treatment satisfaction and opinion of the physician-patient relationship. However, this limitation has been mitigated by the fact that quality of life was additionally evaluated based on the assessment of somatisation, depression, anxiety and hypochondriasis. The success of the EI was followed up only over one-year-period. Unfortunately, we do not have any follow-up data for the participating physicians and patients after one year. We also do not have any follow-up data about the incidence of MUS symptoms after EI, neither about the frequency of patients' attendance at family clinics.

In this study, we decided not to record the occurrence of acute diseases or the worsening frequency of chronic disease, which might have affected the self-rated quality of life in our patients.

5. Conclusions {#j_sjph-2017-0012_s_005}
==============

Education of physicians improved the self-rating of health issues and quality of life by patients with MUS. Moreover, it also helped to reduce symptoms of stress and somatisation, and decreased the level of hypochondriasis, while also improving patients' opinion of the physician-patient relationship. In Slovenia, MUS are still not sufficiently researched as a specific family medicine topic, and approaches to the treatment of patients with MUS have not yet been developed. Considering the results of our study, we find that it is necessary to equip FPs with knowledge, skills and tools for reducing hypochondriasis and somatisation in MUS patients. In this way, we could also improve their self-rated health status. In addition, the observed correlation with stress and anxiety highlights the necessity to manage anxiety in patients with MUS, and strengthen problem-centred strategies for managing stress.

**Conflicts of interest**: The authors declare that they have no conflicts of interest.

Funding {#j_sjph-2017-0012_s_015}
=======

This study was partly supported by the Slovenian Research Agency, Research Programme Code P3-0339.

Ethical Approval {#j_sjph-2017-0012_s_017}
================

The study was approved by the National Medical Ethics Committee of the Republic of Slovenia, Decision No. 45/05/11bis dated 25 May 2011.
